Pharmaceutical formulations of amyloid inhibiting compounds

摘要

Disclosed is a formulation comprising 3-amino-1-propanesulfonic acid, or a salt thereof, and an enteric coating, for oral treatment or prevention of an amyloid-related disease such as Alzheimer's disease, cerebral amyloid angiopathy, inclusion body myositis, macular degeneration, Down's syndrome, mild cognitive impairment, cognitive decline or hereditary cerebral hemorrhage.